Watchlist Price Alert

ABVC BioPharma Inc. (ABVC)

NASDAQ: ABVC · Real-Time Price · USD

2.49

0.30 (13.70%)

At close: Jun 27, 2025, 2:03 PM

ABVC BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Sep 30, 2016
Cash & Equivalents	248.38K	60.16K	85.27K	5.83M	4.27M	144.29K	40.04K	256.93K	173.54K
Short-Term Investments	64.74K	79.31K	75.8K	108.15K	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	2.26M	2.53M	3.68M	932.75K	1.19M	3.36M	3.49M	4.19M	n/a
Other Long-Term Assets	1.95M	1.53M	1.34M	160.47K	164.83K	179.55K	27.42K	-5.77M	3.81K
Receivables	1.16M	759.57K	1.37M	1.71M	999.4K	640.53K	14.64K	n/a	n/a
Inventory	n/a	n/a	1.31M	25.98K	-839.69K	-476.96K	1.32K	199.71K	n/a
Other Current Assets	711.65K	757.68K	1.46M	736.67K	900.36K	16.15K	40.14K	2.55M	n/a
Total Current Assets	2.18M	1.66M	2.99M	9.63M	6.17M	878.24K	96.27K	760.97K	173.54K
Property-Plant & Equipment	1.15M	8.78M	1.74M	2M	2.29M	1.05M	510.07K	570.58K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.36M	12.84M	6.87M	4.07M	5.43M	6.05M	5.37M	5.84M	3.81K
Total Assets	7.54M	14.49M	9.86M	13.7M	11.61M	6.93M	96.27K	6.6M	177.35K
Account Payables	n/a	n/a	n/a	n/a	23.04K	24K	n/a	n/a	18.37K
Deferred Revenue	81.11K	79.5K	10.98K	10.98K	12.07K	13.09K	n/a	n/a	n/a
Short-Term Debt	1.79M	1.47M	1.89M	1.64M	2.09M	4.04M	550K	1.11M	n/a
Other Current Liabilities	3.91M	2.51M	1.04M	n/a	n/a	851.38K	n/a	-1.05M	6.5M
Total Current Liabilities	6.56M	5.93M	5.82M	3.69M	4.84M	6.81M	5.57M	4.09M	56.47K
Long-Term Debt	n/a	n/a	n/a	n/a	2.62M	n/a	250K	n/a	n/a
Other Long-Term Liabilities	21.68K	21.68K	7.98K	10.58K	19.28K	2.88K	27.47K	n/a	n/a
Total Long-Term Liabilities	258.49K	429.14K	420.23K	1.14M	4.1M	238.44K	277.47K	55.69K	60.00
Total Liabilities	6.82M	6.36M	6.24M	4.83M	8.94M	7.05M	5.85M	4.14M	56.53K
Total Debt	2.43M	2.28M	3.05M	3.11M	6.48M	4.58M	800K	1.23M	n/a
Common Stock	13.87K	7.94K	32.86K	28.93K	24.42K	19.48K	213.93K	4.12K	210.82K
Retained Earnings	-68.95M	-65.42M	-54.9M	-38.48M	-25.64M	-15.85M	-19.88M	-9.97M	-4.82M
Comprehensive Income	445.67K	516.39K	517.13K	539.66K	564.86K	663.75K	1M	757.33K	n/a
Shareholders Equity	1.23M	8.39M	3.1M	8.84M	3.44M	-150.96K	-5.75M	1.65M	120.82K
Total Investments	2.32M	2.61M	917.87K	1.04M	1.19M	3.36M	3.49M	4.19M	n/a